Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Sensory and Autonomic Neuropathies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01226316
What this trial is testing

Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules

Who this might be right for
Advanced Solid MalignancySafety and TolerabilityPharmacokinetics+11 more
AstraZeneca 285
Early research (Phase 1)Active Not RecruitingNCT05159700
What this trial is testing

A Phase I Study, Evaluating the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorAdvanced Solid Malignancies
Zhuhai Yufan Biotechnologies Co., Ltd 39
Not applicableStudy completedNCT07759466
What this trial is testing

Hippo Signaling Pathway Proteins in Gingival Crevicular Fluid of Individuals With Periodontal Disease

Who this might be right for
Periodontal DiseaseGingivitis and Periodontal DiseasesBiomarker Discovery and Validation+1 more
Inonu University 75
Testing effectiveness (Phase 2)Ended earlyNCT04899349
What this trial is testing

Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 2
Early research (Phase 1)Looking for participantsNCT07064122
What this trial is testing

AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers)

Who this might be right for
Haematologic Neoplasms
AstraZeneca 72
Testing effectiveness (Phase 2)Looking for participantsNCT04645160
What this trial is testing

Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers

Who this might be right for
CholangiocarcinomaBile Duct NeoplasmBiliary Tract Malignancy
National Cancer Institute (NCI) 31
Large-scale testing (Phase 3)UnknownNCT01050114
What this trial is testing

OnabotulinumtoxinA (onaBoNT-A) Versus Oral Oxybutynin ER

Who this might be right for
Overactive Bladder
Christopher Patrick Smith 36
Testing effectiveness (Phase 2)Ended earlyNCT02718300
What this trial is testing

INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis

Who this might be right for
MPN (Myeloproliferative Neoplasms)
Incyte Corporation 74
Large-scale testing (Phase 3)Ended earlyNCT03439046
What this trial is testing

Study of the Molecular Features of Postmenopausal Women With HR+ HER2-negative aBC on First-line Treatment With Ribociclib and Letrozole and, in Patients With a PIK3CA Mutation, on Second-line Treatment With Alpelisib Plus Fulvestrant

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 287
Testing effectiveness (Phase 2)Looking for participantsNCT05768139
What this trial is testing

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Who this might be right for
Breast CancerSolid Tumors, Adult
Eli Lilly and Company 880
Testing effectiveness (Phase 2)WithdrawnNCT02624310
What this trial is testing

Norepinephrine in Patients With Congenital Insensitivity to Pain and Anhidrosis

Who this might be right for
HSAN Type IV
NYU Langone Health
Not applicableLooking for participantsNCT05868629
What this trial is testing

Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors

Who this might be right for
Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors
Novartis Pharmaceuticals 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT07543822
What this trial is testing

24VA022; VATCH Alpelisib for TIE2/PIK3CA Pathway VAs

Who this might be right for
Vascular AnomaliesVascular AnomalyTIE2/PIK3CA Pathway Driven Vascular Anomalies
Children's Hospital of Philadelphia 61
Not applicableUnknownNCT05652751
What this trial is testing

Effect of EA Combined With NGF on Limb Function in Convalescent Patients With Ischemic Stroke

Who this might be right for
Ischemic Stroke
The Third Affiliated hospital of Zhejiang Chinese Medical University 120
Testing effectiveness (Phase 2)Study completedNCT04218071
What this trial is testing

Actuate 1901: 9-ING-41 in Myelofibrosis

Who this might be right for
Myelofibrosis
Actuate Therapeutics Inc. 17
Early research (Phase 1)Ended earlyNCT02292225
What this trial is testing

Duvelisib With Obinutuzumab in Patients With CLL/SLL Previously Treated With a BTKi (SYNCHRONY)

Who this might be right for
Lymphocytic Leukemia, ChronicLymphoma, Small Lymphocytic
SecuraBio 3
Large-scale testing (Phase 3)Not Yet RecruitingNCT07475065
What this trial is testing

The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy

Who this might be right for
Diabetic PolyneuropathyPeripheral Nervous System DiseasesPeripheral Neuropathy+1 more
Universitas Sebelas Maret 34
Not applicableWithdrawnNCT03911063
What this trial is testing

Telemedicine Clinical Trial for Cognitive Behavioral Therapy in Familial Dysautonomia

Who this might be right for
Familial Dysautonomia
NYU Langone Health
Early research (Phase 1)Looking for participantsNCT07543991
What this trial is testing

Intraneural Administration of scAAV9/JeT-GAN Into the Vagus Nerve for Patients With Giant Axonal Neuropathy (GAN)

Who this might be right for
Giant Axonal Neuropathy (GAN)
University of Texas Southwestern Medical Center 4
Testing effectiveness (Phase 2)Study completedNCT01276379
What this trial is testing

Study Evaluating Biomarkers in Patients With Colorectal Cancer and Native KRAS Treated With Chemotherapy + Cetuximab

Who this might be right for
Colorectal Cancer
Grupo Espanol Multidisciplinario del Cancer Digestivo 221
Next Page